Document Citation: 7 Alaska Admin. Code 27.007

Header:
ALASKA ADMINISTRATIVE CODE
TITLE 7. HEALTH AND SOCIAL SERVICES
PART 2. PUBLIC HEALTH
CHAPTER 27. PREVENTIVE MEDICAL SERVICES
ARTICLE 1. CONTROL OF DISEASES OF PUBLIC HEALTH IMPORTANCE


Date:
08/31/2009

Document:

7 AAC 27.007. Reporting by laboratories

(a) An infectious agent listed in this subsection constitutes a public health emergency requiring immediate reporting. A public, private, military, hospital, or other laboratory performing serologic, immunologic, microscopic, biochemical, or cultural examinations or tests in this state or on samples obtained within this state must immediately report evidence of human infection caused by the following agents by telephone directly to a public health agent in the department when the infectious agent is identified or suspected by the laboratory. The following infectious agents must be reported under this section:

(1) Bacillus anthracis;

(2) Clostridium botulinum or botulinum toxin;

(3) Corynebacterium diphtheriae;

(4) Francisella tularensis;

(5) Hemorrhagic fever viruses;

(6) Neisseria meningitidis;

(7) poliovirus;

(8) rabies virus;

(9) rubella virus;

(10) rubeola (measles) virus;

(11) SARS - associated coronavirus;

(12) suspected novel strains of influenza virus;

(13) variola (smallpox) virus;

(14) Yersinia pestis.

(b) In addition to the immediate reporting requirements of (a) of this section, a public, private, military, hospital, or other laboratory performing serologic, immunologic, microscopic, biochemical, or cultural examinations or tests in this state or on samples obtained within this state must report evidence of human infection caused by the following agents at the time of identification or suspected identification to the division of public health in the department in a manner set out in (c) of this section:

(1) Bacillus anthracis;

(2) Bordetella pertussis;

(3) Borrelia burgdorferi;

(4) Brucella species;

(5) Campylobacter species;

(6) Chlamydia psittaci;

(7) Chlamydia trachomatis;

(8) Clostridium botulinum or botulinum toxin;

(9) Clostridium tetani;

(10) Corynebacterium diphtheriae;

(11) Coxiella burnetii;

(12) Cryptosporidium species;

(13) Cyclospora;

(14) Escherichia coli 0157

(15) Echinococcus species;

(16) Francisella tularensis;

(17) Giardia lamblia;

(18) Haemophilus ducreyi;

(19) Haemophilus influenzae from normally sterile body fluid or site;

(20) Hemorrhagic fever viruses;

(21) hepatitis A, B, or C virus;

(22) human immunodeficiency virus (HIV);

(23) influenza virus;

(24) Legionella species;

(25) Listeria monocytogenes;

(26) mumps virus;

(27) Mycobacterium leprae;

(28) Mycobacterium tuberculosis;

(29) Neisseria gonorrhoeae;

(30) Neisseria meningitidis;

(31) Plasmodium species;

(32) poliovirus;

(33) prions;

(34) rabies virus;

(35) rubella virus;

(36) rubeola (measles) virus;

(37) Salmonella species;

(38) SARS - associated coronavirus;

(39) Shigella species;

(40) Streptococcus pneumoniae from normally sterile body fluid or site;

(41) Streptococcus pyogenes from normally sterile body fluid or site;

(42) Streptococcus agalactiae from normally sterile body fluid or site;

(43) Treponema pallidum;

(44) Trichinella species;

(45) varicella virus;

(46) variola (smallpox) virus;

(47) Vibrio species;

(48) West Nile virus;

(49) yellow fever virus;

(50) Yersinia enterocolitica or Y. pseudotuberculosis;

(51) Yersinia pestis.

(c) To meet the reporting requirements of (b) of this section, a public, private, military, hospital, or other laboratory must submit a report to the division orally, electronically, or on a form provided by the division or on a legible copy of the original laboratory report form within five working days after the examination or test is performed. Each notification must give the date and result of the examination or test performed, the name or identification code sufficient to identify the patient to the health care provider, and, if available, the date of birth, sex, race, and ethnicity of the patient from whom the specimen was obtained and the name and address of the health care provider for whom the examination or test was performed.

(d) When acting on the basis of information received from a report made under this section, the public health agent shall first attempt to contact the health care provider for whom the examination or test was performed before contacting the patient directly.